Samuel Levy

Samuel Levy is the CEO & Chief Scientific Officer at Bluestar Genomics. Samuel has more than 20 years of scientific leadership in genomics and molecular diagnostic development. Previously, he was Founder and Chief Scientific Officer at Impact Genomics (dba Lexent Bio).

Samuel earned his Ph.D. in Cell Biology and Computer Simulation from the University of Bristol in 1986.